(IN201727036771) Astaxanthin compositions (iv) 机翻标题: 暂无翻译,请尝试点击翻译按钮。

源语言标题
Astaxanthin compositions (iv)
公开号/公开日
IN201727036771 A 2017-12-01 [IN201727036771] / 2017-12-01
申请号/申请日
2017IN-27036771 / 2017-10-17
发明人
Alexandra RAUSCH Tamara;Claudia SCHOLTEN;Bernd SCHAEFER;FELDTHUSEN JENSEN Jesper;
申请人
BASF;
主分类号
IPC分类号
A23K-020/105A61K-031/202C07C-403/24
摘要
(IN201727036771) The invention relates to astaxanthin compositions for use in foods food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions which contain at least 50 wt.% in particular at least 60 wt.% more particularly at least 70 wt.% and especially at least 80 wt.% or at least 90 wt.% relative to the total weight of astaxanthin and astaxanthin derivatives in the composition a monoester of the astaxanthin having C18 1 fatty acid have a particularly high bioavailability.  They are therefore particularly suitable for use in foods food supplements or animal feed and for therapeutic use as a medicament and as an ingredient for medical preparations or pharmaceutical agents.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2015EP-0159833 2015-03-19
主权利要求
(IN201727036771)  1. The use of astaxanthin compositions in foodstuffs, food supplements or feedstuffs, where the astaxanthin composition comprises at least 50% by 5. Weight, based on the total weight of astaxanthin and astaxanthin derivatives in the composition, of at least one monoester of astaxanthin with a C18-1 Fatty acid. 2. The use according to claim 1, wherein less than 30% by weight of the 10. Astaxanthin present in the astaxanthin composition, based on the total weight of astaxanthin and astaxanthin derivatives in the composition is present in the form of a monoester of astaxanthin with an aliphatic C16-C22- Monocarboxylic acid which is other than the C18-1-fatty acid. 15. 3. The use according to claim 1 or 2, wherein at least 90% by weight of the astaxanthin monoester present in the astaxanthin composition are present in the form of a monoester of astaxanthin with the C18-1 fatty acid. 4. The use acording to claim 2 or 3, wherein the astaxanthin monoesters other 20. Than the monoester of astaxanthin with a C18-1-fatty acid are selected from among monoesters with one fatty acid selected among C18-0, C18-2, C18- 3. And C18-4. 5. The use according to any of the preceding claims, wherein less than 60% 25. By weight of the unsaturated fatty acids which are present in the astaxanthin monoester are present as trans-fatty acids. 6. The use according to any of the preceding claims, wherein at least 40% by weight of the astaxanthin monoester are present in the form of monoesters 30. Of all-trans astaxanthin. 7. The use according to any of the preceding claims, wherein at least 90% by weight of the astaxanthin monoester are present in the form of monoesters of an astaxanthin which either has the (S) or the (R) configuration in the 35. Asymmetric centers in positions 3 and 3', respectively. 8. A composition in the form of a food additive, feed additive or food supplement, comprising an astaxanthin composition according to any of 29.  Claims 1 to 7 and an adjuvant which is suitable for foodstuffs, feedstuffs or food supplements. 9. The composition according to claim 8, selected among solutions and 5. Suspensions of the astaxanthin composition and an oil or fat which is suitable for foodstuffs or feedstuffs. 10. The composition according to claim 8 in the form of a powder, comprising an astaxanthin composition and a protective colloid.  10. 11. The composition according to claim 8 in the form of a food supplement for oral administration. 12. A foodstuff, comprising an astaxanthin composition according to any of 15. Claims 1 to 7, wherein the concentration of the astaxanthin composition corresponds to the astaxanthin content which is approved for foodstuffs. 13. A feedstuff, comprising an astaxanthin composition according to any of claims 1 to 7, wherein the concentration of the astaxanthin composition 20. Corresponds to the astaxanthin content which is approved for feedstuffs. 14. A process for the preparation of a foodstuff or feedstuff, comprising the addition of an astaxanthin composition according to any of claims 1 to 7 to a conventional foodstuff or feedstuff.  25. 15. The astaxanthin composition according to any of claims 1 to 7 for the therapeutic use as medicament and as constituent for a medicinal preparation. 30. 16. The astaxanthin composition according to claim 15 for the treatment or prevention of joint diseases, eye diseases, skin diseases, skin aging, heart diseases, diseases of the blood vessels, inflammatory diseases, tumor diseases, bacterial infections, type-2 diabetes and associated sequelae, And degenerative nerve disorders, for improving male fertility, memory, 35. Physical fitness and concentration and for strengthening the immune system. 17. A medicinal preparation, comprising an astaxanthin composition according to any of claims 1 to 7 and at least one pharmaceutically suitable auxiliary. 18. 30.
法律状态
(IN201727036771) LEGAL DETAILS FOR IN201727036771  Actual or expected expiration date=2037-10-17    Legal state=ALIVE    Status=PENDING     Event publication date=2017-10-17  Event code=IN/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=IN IN201727036771  Application date=2017-10-17  Standardized application number=2017IN-27036771     Event publication date=2017-12-01  Event code=IN/A  Event indicator=Pos  Event type=Examination events  Application laid open  Publication country=IN  Publication number=IN201727036771  Publication stage Code=A  Publication date=2017-12-01  Standardized publication number=IN201727036771
专利类型码
A
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部